Lantern Pharma Inc. (LTRN) Discusses Open-Medicine AI Platform Roadmap, Business Model, and Value Proposition for Therapeutic Development - Slideshow

🇺🇸 Seeking Alpha (US) — 2026-09-24

Lantern Pharma Inc. detailed its Open-Medicine AI platform roadmap and business model focusing on therapeutic development. The company aims to leverage AI technologies to enhance drug discovery and development efficiency.

Markets Deals AI & Tech Lantern Pharma AI platform therapeutic development drug discovery biotech

Read original source →

Tikehau Capital-backed EYSA acquires B2B corporate mobility platform Joinup
PE Hub — 2026-09-24
Morning recap: NMDPRA cracks down on petrol under-dispensing, APC challenges Atiku’s substituted service request, other top stories
Punch Nigeria — 2026-09-24
Petrobras Eyes Sirius Gas Project for 2027-2031 Business Plan
Offshore Engineer — 2026-09-24
Only RM6.7m recovered from RM2.97b scams, Lim Guan Eng demands urgent action
Malay Mail — 2026-09-24
UK's Raspberry Pi posts record first half on strong industrial demand
Channel NewsAsia — 2026-09-24
Germany to abandon fossil fuels by 2045. How does the rest of Europe compare?
Euronews — 2026-09-24

Lantern Pharma Inc. (LTRN) Discusses Open-Medicine AI Platform Roadmap, Business Model, and Value Proposition for Therapeutic Development - Slideshow

AI Summary

Related Articles

Tikehau Capital-backed EYSA acquires B2B corporate mobility platform Joinup

Morning recap: NMDPRA cracks down on petrol under-dispensing, APC challenges Atiku’s substituted service request, other top stories

Petrobras Eyes Sirius Gas Project for 2027-2031 Business Plan

Only RM6.7m recovered from RM2.97b scams, Lim Guan Eng demands urgent action

UK's Raspberry Pi posts record first half on strong industrial demand

Germany to abandon fossil fuels by 2045. How does the rest of Europe compare?